Liberalized Investment Rules Boosting Saudi Arabian Healthcare Market

Saudi Arabian Healthcare Industry is projected to grow at a CAGR of around 9.2% during 2013-2017, says RNCOS.


Noida, UP -- (SBWIRE) -- 09/04/2015 -- Saudi Arabia has taken significant steps to improve the quality of healthcare over the past decades. But the system is still heavily reliant on acute hospital based care model. The government has recognized this situation, and has identified healthcare as one of the key sectors targeted in its wide-ranging privatization program. For widening the program Saudi Arabia has introduced new rules that aim to liberalise the country's healthcare sector and open it for increased investments. Driven by the above factor, Saudi Arabian healthcare industry is slated to grow at a CAGR of 9.2% during the forecast period of 2015-2020.

According to our latest research study, "Saudi Arabian Healthcare Outlook 2020", liberalized investment rules, and compulsory healthcare insurance policies would help the Saudi Arabian healthcare market to grow in the coming years. Kingdom's healthcare market, although growing steadily, has been largely restricted by local ownership rules. Saudi Arabia's foreign investors in the past were permitted to set up hospitals in major cities with a minimum of 150 beds and in rural areas with at least 40 beds. This effectively barred non-Saudis from owning clinical centres in the Kingdom. Saudi healthcare sector will largely benefit from this liberalization.

The report by RNCOS spread over 110 pages provides an in-depth research and rational analysis of the current status and future growth prospects of the healthcare market in Saudi Arabia. Our research includes detailed study on the healthcare infrastructure, hospital bed capacity, hospital health force, hospital occupancy rate and average length of stay. Besides that, the report exhibits the emerging trends and drivers in the Kingdom which are boosting the growth of healthcare market.

The report further provides a detailed description of pharmaceutical and medical device market in Saudi Arabia along with the market overview, import structure and domestic production. A regulatory framework has been provided in the report for a better understanding of registration rules for pharmaceutical products and medical devices in the country. Through the section of regional analysis we have tried to provide the insight of current market scenario in different regions of the Kingdom. Additionally, we have also covered the key players section which gives a proper understanding to our customers about the existing competition in healthcare market. As a whole, the report represents a comprehensive outlook of the sector's past, present, and future scenario.

For FREE SAMPLE of this report visit:

Check Related REPORTS on:

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.